Loading clinical trials...
Loading clinical trials...
Thrombin Generation and Gestational Outcome in Women With Recurrent Pregnancy Loss
In total 120 pregnant women's with history of recurrent miscarriages, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). The relation between pregnancy outcome and thrombin measurements will be determined
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Haemek medical center
Afula, Israel
Start Date
October 1, 2013
Primary Completion Date
September 1, 2016
Completion Date
December 1, 2017
Last Updated
March 1, 2018
29
ACTUAL participants
Lead Sponsor
HaEmek Medical Center, Israel
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01905748